Treatment success seen with antibiotics for uncomplicated appendicitis

Treatment success seen with antibiotics for uncomplicated appendicitis

(HealthDay)—For adults with uncomplicated acute appendicitis, treatment success rates ≥65 percent are seen with both oral antibiotics and combined intravenous and oral antibiotics, according to a study published online Jan. 11 in the Journal of the American Medical Association.

Suvi Sippola, M.D., from Turku University Hospital in Finland, and colleagues compared oral antibiotics to combined intravenous followed by oral antibiotics in 599 aged 18 to 60 years with computed tomography-confirmed uncomplicated acute appendicitis. Participants were randomly assigned to either oral moxifloxacin for seven days or intravenous ertapenem for two days followed by oral levofloxacin and metronidazole for five days. Overall, 581 patients were available for one-year follow-up. The primary end point was treatment success (≥65 percent); a margin of 6 percent for the difference between the treatment groups was used to determine noninferiority of oral antibiotics alone.

The researchers found that the rate at one year was 70.2 and 73.8 percent for patients treated with oral antibiotics and intravenous followed by , respectively. The difference was −3.6 percent (P = 0.26 for noninferiority), with the confidence limit exceeding the margin for noninferiority.

"The current evidence supports that patients with uncomplicated appendicitis should be offered a treatment choice between surgery and antibiotics alone," write the authors of an accompanying editorial. "The key to moving forward is getting that evidence into practice."

Several authors disclosed financial ties to the .

More information: Abstract/Full Text

Copyright © 2020 HealthDay. All rights reserved.

Citation: Treatment success seen with antibiotics for uncomplicated appendicitis (2021, January 12) retrieved 27 February 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Oral antibiotics noninferior to IV for bone, joint infection


Feedback to editors